Search companies

Live

BIO-GENE TECHNOLOGY LTD (ASX: BGT)

Materials · News and insights

Price unavailable

Latest BGT announcements

Bio-Gene Targets Flavocide Regulatory Filing As Japan Qcide Preparations Advance

2026-10-30 · Materials

BGT: $0.014 +7.69% · MC: $7M

Bio-Gene says it is targeting an initial Australian regulatory application for Flavocide in the second quarter of 2027, subject to completing studies and preparing the submission; draft reports for two key toxicity studies are under review. Work with Sumitomo and Nakashima on documentation and product development for Qcide supply to Japan continues, but timing for a first commercial order has not been agreed. The company also reported approximately $3 million in gross proceeds from its placement and share purchase plan, and received an R&D tax incentive of approximately $343,000 after quarter-end.

Updated 2026-10-30 11:26
Share
SourcesNotice of Annual General Meeting/Proxy FormQuarterly Activities/Appendix 4C Cash Flow Report
Comments

Bio-Gene Technology proposes 6.5 million incentive options for directors and management

2026-10-28 · Materials

BGT: $0.013 -23.53% · MC: $7M

Bio-Gene Technology proposes issuing 6.5 million options expiring in 2029 as incentives for directors and management. The proposed issue includes 4.5 million options for directors, subject to shareholder approval at the AGM, and 2 million for management, which do not require approval.

Updated 2026-10-28 11:14
Share
SourcesProposed issue of securities - BGT
Comments